Episode 451: ESMO 2025 - PSMAddition

summaryThis detailed discussion covers the latest phase three trial results in kidney cancer, focusing on LITESPARK 011: Belzutifan and Levatnib combination versus Cabozantinib. Brian, Tom and Bob Motzer analyze efficacy, safety, and implications for treatment sequencing. 

This in-depth discussion explores the latest advancements in adjuvant kidney cancer treatment, focusing on the recent phase 3 trial results of Belzutifan combined with Pembrolizumab, mechanistic insights, biomarker development, and future research directions. 

Prof Jorge Sierra provides an overview of myeloma, delving into its clinical aspects and sharing his personal passion for the disease. Together with host Prof. Konstanze Döhner, they explore myeloma's treatment challenges and advancements. Prof. Sierra also offers valuable advice ...  Show more

Pedro Martinez joins Jimmy Rollins & Ryan Howard to talk pitchers in today’s game and his time with the Phillies! To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastcho ...  Show more

This podcast episode is all about new perspectives on stuttering. This is the first of a two-part series, so be sure to tune in for part two in two weeks. Listen to part one to learn more and don't forget to check out the links and resources by accessing the show notes here: h ...

"X". Calle Alcalá, Madrid. Photograph by Ana M. Martín Solar. With the evocative title “Once Again, the Mystery”, the Argentine psychoanalyst Mariano Horenstein poses the equally enigmatic question: How do we listen to the language of sexuality today? Through an exploration of th ...  Show more